Owner Basilea Pharmaceutica AG

Inventors Page, Malcolm G. P.; Desarbre, Eric; Gaucher, Berangere; Roussel, Patrick

Agent Spruson & Ferguson

Pub. Number AU-B-2006322564

PCT Pub. Number WO2007/065288

Priority 05026699.8 07.12.05 EP; 06006291.6 27.03.06 EP

Filing date 7 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 9 September 2010

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/43 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/69 (2006.01) - Boron compounds

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups